The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
A Birmingham study reveals a novel cellular phenomenon could be responsible for the onset of primary biliary cholangitis (PBC).
First study tracking how NK cells respond in tumours found that stimulating the IL-15 pathway prevented the rapid loss of function and improved tumour control
Dr Shivan Sivakumar, a nationally recognised oncologist in cancers of the pancreas, liver and biliary tract, joins the College of Medical and Dental Sciences.
Dr Sally Clayton will study a novel pathway that becomes dysregulated in inflammatory diseases and how it controls the function in immune cells.
New funding, announced by the Medical Research Council, will support BactiVac, the Bacterial Vaccines Network as well as other global vaccine research.
Inhibiting a protein involved in liver inflammation has the potential to reduce or stop fibrosis in patients with non-alcoholic steatohepatitis, trial finds
For the first time, researchers have shown a direct link between a blood vessel protein and cell growth arrest in the liver
The University of Birmingham-hosted BactiVac Network secures major funding to accelerate the development of bacterial vaccines.
Parth Narendran, Professor of Diabetes Medicine, has been awarded £860K funding towards type 1 diabetes general population screening of young people in Europe.
Professor Paul Moss has been appointed as the new Chair of the Medical Research Foundation’s Board of Trustees, with effect from October 2023.
Study received £2.8m of Department of Health and Social Care funding to find out if testing can identify which immunosuppressed people remain at greatest risk.